Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14151 - 14175 of 14364 in total
Iguratimod is under investigation in Rheumatoid Arthritis.
Investigational
Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental
T-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Investigational
Roluperidone has been used in trials studying the treatment of Schizophrenia.
Investigational
Investigational
EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.
Investigational
Matched Description: … enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and
RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and stroke by Dr. Reddy’s Laboratories. The drug’s Phase I clinical trials have been initiated in Europe to assess safety of the drug compound in healthy volunteers.
Investigational
Matched Description: … the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and
Vapitadine is an antihistamine that Barrier Therapeutics is developing as a treatment for allergic reactions of the skin, such as those associated with hives and for the itch associated with atopic dermatitis. An advantage of vapitadine over other antihistamines may be the absence of the sedation, even at high doses.
Investigational
Matched Description: … is developing as a treatment for allergic reactions of the skin, such as those associated with hives and
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational
Experimental
Illicit
Displaying drugs 14151 - 14175 of 14364 in total